We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESAB icon
4351
ESAB
ESAB
$5.32B
$1.07M ﹤0.01%
11,345
-11,653
-51% -$1.21M
AVNS
4352
DELISTED
Avanos Medical
AVNS
$1.07M ﹤0.01%
53,769
-25,990
-33% -$506K
IBHD
4353
DELISTED
iShares iBonds 2024 Term High Yield and Income ETF
IBHD
$1.07M ﹤0.01%
46,045
+10,947
+31% +$254K
ZYME icon
4354
Zymeworks
ZYME
$1.71B
$1.07M ﹤0.01%
125,674
+58,250
+86% +$519K
COGT icon
4355
Cogent Biosciences
COGT
$7.1B
$1.07M ﹤0.01%
126,539
-304,466
-71% -$2.31M
NNAG
4356
DELISTED
99 Acquisition Group Inc
NNAG
$1.07M ﹤0.01%
101,573
+101,501
+140,974% +$1.06M
TGLS icon
4357
Tecnoglass Holdings Inc.
TGLS
$1.84B
$1.07M ﹤0.01%
21,250
-201,550
-90% -$10.5M
GLU
4358
Gabelli Utility & Income Trust
GLU
$116M
$1.06M ﹤0.01%
76,808
+6,174
+9% +$87.5K
JRI icon
4359
Nuveen Real Asset Income & Growth Fund
JRI
$349M
$1.06M ﹤0.01%
87,443
-28,955
-25% -$335K
CYH icon
4360
Community Health Systems
CYH
$415M
$1.06M ﹤0.01%
316,499
+137,371
+77% +$462K
THD icon
4361
iShares MSCI Thailand ETF
THD
$357M
$1.06M ﹤0.01%
19,589
+8,185
+72% +$472K
EQX icon
4362
Equinox Gold
EQX
$13.5B
$1.06M ﹤0.01%
202,981
+52,013
+34% +$290K
BYM
4363
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$1.06M ﹤0.01%
92,633
-11,625
-11% -$130K
ALT icon
4364
Altimmune
ALT
$593M
$1.06M ﹤0.01%
159,601
-330,400
-67% -$2.44M
BSMT icon
4365
Invesco BulletShares 2029 Municipal Bond ETF
BSMT
$283M
$1.06M ﹤0.01%
46,289
-1,855
-4% -$42.6K
CSTL icon
4366
Castle Biosciences
CSTL
$988M
$1.06M ﹤0.01%
48,723
-6,120
-11% -$136K
DIM icon
4367
WisdomTree International MidCap Dividend Fund
DIM
$168M
$1.06M ﹤0.01%
17,494
-40
-0.2% -$2.49K
CMP icon
4368
Compass Minerals
CMP
$1.13B
$1.06M ﹤0.01%
102,488
+73,024
+248% +$942K
TGNA
4369
DELISTED
TEGNA Inc
TGNA
$1.06M ﹤0.01%
75,938
-188,325
-71% -$2.66M
SWI
4370
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.06M ﹤0.01%
87,806
-25,696
-23% -$297K
TEN
4371
Tsakos Energy Navigation Ltd
TEN
$1.15B
$1.05M ﹤0.01%
36,018
+7,224
+25% +$203K
W icon
4372
PUT
Wayfair
W
$14.1B
$1.05M ﹤0.01%
20,000
-61,300
-75% -$3.64M
BMBL icon
4373
Bumble
BMBL
$360M
$1.05M ﹤0.01%
100,329
-445,950
-82% -$4.86M
MRSH
4374
CALL
Marsh
MRSH
$91B
$1.05M ﹤0.01%
+5,000
New +$1.03M
ITGR icon
4375
Integer Holdings
ITGR
$4.25B
$1.05M ﹤0.01%
9,098
-14,964
-62% -$1.75M

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.